REBLOZYL® (luspatercept-aamt) for the Treatment of Anaemia Associated with Beta-Thalassemia
REBLOZYL® (luspatercept-aamt) is administered through a subcutaneous injection with a starting dose of 1mg/kg. Credit: Celgene Corporation.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
KPS
Founded in 2010, KPS is a Functional Service Provider (FSP)...
About
Founded in 2010, KPS is a Functional Service Provider (FSP) offering Clinical Monitoring, Project Management and CRO Oversight solutions to the biopharmaceutical industry.
FollowMake an Enquiry
-
VaLea Clinical Trials
VaLea Clinical Trials specialises in providing convenient patient-centric services for...
About
VaLea Clinical Trials specialises in providing convenient patient-centric services for clinical trials in the home or alternate-site settings, based in Vienna, Austria.
FollowMake an Enquiry
-
Malvern Panalytical
Malvern Panalytical offers characterisation tools for molecular analysis and small...
About
Malvern Panalytical offers characterisation tools for molecular analysis and small drug discovery to help accelerate development for the pharmaceutical industry.
FollowMake an Enquiry